Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Heart failure (Spironolactone - Heart failure)

Records returned : 29 (on 29 May 2025 at 12:58:47). Return to search results for ' Heart failure '.

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
1.
Drug:
Indication :
Status :
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
Indication :
Status :
Green
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important
Preferred
Spironolactone is the preferred aldosterone antagonist for all stages of heart failure.
 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Preferred
 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred
Preferred angiotensin II receptor blocker.
 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Green
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important
ONE 62.5microgram tablet is approximately equivalent to 50microgram (1mL) elixir
 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Oro-dispersible
Restrictions / Comments:

Important
Only licensed for use in children.
 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
2mg, 4mg and 8mg tablets. Do not prescribe as perindopril arginine.
 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Green
Formulations :
  • Capsules
Restrictions / Comments:

Preferred
 
Links :
Indication :
Status :
Green
Formulations :
  • Capsules
Restrictions / Comments:

 
Links :
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Initiation restricted to cardiology. Transfer to primary care only after initiation and at least the first month supply from the specialist.
 
Links :
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Transfer of prescribing to primary care only after initiation and stabilisation by the specialist.
 
Links :
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Restricted to initiation by cardiology only. Transfer of prescribing to primary care only after initiation and at least the first month supply from the specialist.
 
Links :
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Initiation by specialist. The licensed (Xaqua) and unlicensed (Zaroxolyn) tablets have different bioavailabilities. These products are not interchangable=Prescribe by Brand
 
Links :
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Prescribing in primary care on specialist recommendation.
 
Links :
Indication :
Status :
Amber
Formulations :
  • Tablets
Restrictions / Comments:

Important
Do not co-administer with an ACEi or ARB due to risk of angioedema.
 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Granules
Restrictions / Comments:

Important
Do not co-administer with an ACEi or ARB due to risk of angioedema.

Only licensed for use in children.

 
Links :
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important

Off label. Acutely decompensated heart failure. RSCH Cardiology only

 
Links :
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
Indication :
Status :
Red
Formulations :
  • Intravenous infusion
Restrictions / Comments:

Important
Acutely decompensated heart failure. Unlicensed. Restricted to cardiology / ICU only. Use according to protocol
 
Links :
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Restricted use: ITU only at SASH Consultants only at RSCH
 
Links :